These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 26193429)

  • 1. Management of nodal recurrences of endometrial cancer with IMRT.
    Ho JC; Allen PK; Jhingran A; Westin SN; Lu KH; Eifel PJ; Klopp AH
    Gynecol Oncol; 2015 Oct; 139(1):40-6. PubMed ID: 26193429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation dose escalation using intensity modulated radiation therapy for gross unresected node-positive endometrial cancer.
    Townamchai K; Poorvu PD; Damato AL; DeMaria R; Lee LJ; Berlin S; Feltmate C; Viswanathan AN
    Pract Radiat Oncol; 2014; 4(2):90-98. PubMed ID: 24890349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FIGO stage IIIC endometrial carcinoma with metastases confined to pelvic lymph nodes: analysis of treatment outcomes, prognostic variables, and failure patterns following adjuvant radiation therapy.
    Nelson G; Randall M; Sutton G; Moore D; Hurteau J; Look K
    Gynecol Oncol; 1999 Nov; 75(2):211-4. PubMed ID: 10525373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical outcomes and toxicity in endometrial cancer patients treated with adjuvant intensity-modulated radiation therapy or conventional radiotherapy.
    Chen CC; Wang L; Lu CH; Lin JC; Jan JS
    J Formos Med Assoc; 2014 Dec; 113(12):949-55. PubMed ID: 24144528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes.
    Poorvu PD; Sadow CA; Townamchai K; Damato AL; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1262-8. PubMed ID: 23182395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodal Clearance Rate and Long-Term Efficacy of Individualized Sentinel Node-Based Pelvic Intensity Modulated Radiation Therapy for High-Risk Prostate Cancer.
    Müller AC; Eckert F; Paulsen F; Zips D; Stenzl A; Schilling D; Alber M; Bares R; Martus P; Weckermann D; Belka C; Ganswindt U
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):263-71. PubMed ID: 26853335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended field intensity modulated radiation therapy with concomitant boost for lymph node-positive cervical cancer: analysis of regional control and recurrence patterns in the positron emission tomography/computed tomography era.
    Vargo JA; Kim H; Choi S; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Beriwal S
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1091-8. PubMed ID: 25303889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of adjuvant chemotherapy and pelvic radiotherapy in high-risk early stage endometrial carcinoma.
    Jutzi L; Hoskins P; Lim P; Aquino-Parsons C; Tinker A; Kwon JS
    Gynecol Oncol; 2013 Dec; 131(3):581-5. PubMed ID: 24055614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial.
    Klopp AH; Enserro D; Powell M; Randall M; Schink JC; Mannel RS; Holman L; Bender D; Kushnir CL; Backes F; Zweizig SL; Waggoner S; Bradley KA; Lawrence LD; Hanjani P; Darus CJ; Small W; Cardenes HR; Feddock JM; Miller DS
    J Clin Oncol; 2024 Jul; 42(20):2425-2435. PubMed ID: 38662968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multi-Institutional Analysis of Adjuvant Chemotherapy and Radiation Sequence in Women With Stage IIIC Endometrial Cancer.
    Hathout L; Wang Y; Wang Q; Vergalasova I; Elshaikh MA; Dimitrova I; Damast S; Li JY; Fields EC; Beriwal S; Keller A; Kidd EA; Usoz M; Jolly S; Jaworski E; Leung EW; Donovan E; Taunk NK; Chino J; Natesan D; Russo AL; Lea JS; Albuquerque KV; Lee LJ
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1423-1431. PubMed ID: 33677053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes using adjuvant pelvic intensity modulated radiation therapy (IMRT) for endometrial carcinoma.
    He S; Gill BS; Heron DE; Kelley JL; Sukumvanich P; Olawaiye AB; Edwards RP; Comerci J; Beriwal S
    Pract Radiat Oncol; 2017; 7(1):19-25. PubMed ID: 27527897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does external beam radiation boost to pelvic lymph nodes improve outcomes in patients with locally advanced cervical cancer?
    Wujanto C; Choo BA; Tan D; Ilancheran A; Ng J; Low JJH; Shen L; Tang J; Koh V
    BMC Cancer; 2019 Apr; 19(1):385. PubMed ID: 31023261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of treatment outcomes between involved-field and elective nodal irradiation in limited-stage small cell lung cancer.
    Han TJ; Kim HJ; Wu HG; Heo DS; Kim YW; Lee SH
    Jpn J Clin Oncol; 2012 Oct; 42(10):948-54. PubMed ID: 22811409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC; Wang L; Lin JC; Jan JS
    J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the incidence of isolated paraaortic nodal recurrence in grade 1 endometrial carcinoma?
    Abu-Rustum NR; Chi DS; Leitao M; Oke EA; Hensley ML; Alektiar KM; Barakat RR
    Gynecol Oncol; 2008 Oct; 111(1):46-8. PubMed ID: 18657853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer.
    Viswanathan AN; Moughan J; Miller BE; Xiao Y; Jhingran A; Portelance L; Bosch WR; Matulonis UA; Horowitz NS; Mannel RS; Souhami L; Erickson BA; Winter KA; Small W; Gaffney DK
    Cancer; 2015 Jul; 121(13):2156-63. PubMed ID: 25847373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intensity modulated radiation therapy for patients with gynecological malignancies after hysterectomy and chemotherapy/radiotherapy].
    Chen ZY; Ma YB; Sheng XG; Zhang XL; Xue L; Song QQ; Liu NF; Miao HQ
    Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):305-8. PubMed ID: 17760262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods, safety, and early clinical outcomes of dose escalation using simultaneous integrated and sequential boosts in patients with locally advanced gynecologic malignancies.
    Boyle J; Craciunescu O; Steffey B; Cai J; Chino J
    Gynecol Oncol; 2014 Nov; 135(2):239-43. PubMed ID: 25192879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-abdominal radiation in endometrial carcinoma: an analysis of toxicity, patterns of recurrence, and survival.
    Small W; Mahadevan A; Roland P; Vallow L; Zusag T; Fishman D; Massad S; Rademaker A; Kalapurakal JA; Chang S; Lurain J
    Cancer J; 2000; 6(6):394-400. PubMed ID: 11131490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative pelvic intensity-modulated radiotherapy in high risk endometrial cancer.
    Shih KK; Milgrom SA; Abu-Rustum NR; Kollmeier MA; Gardner GJ; Tew WP; Barakat RR; Alektiar KM
    Gynecol Oncol; 2013 Mar; 128(3):535-9. PubMed ID: 23174538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.